SecBot SecBot

A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.

S. 708 Sen. Sherrod Brown (D-OH) In committee
  1. Introduced Mar 8
  2. Committee Mar 8
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Mar 8, 2023Next: Senate vote
1330d ago Mar 8, 2023: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 2 filings
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill requires the Centers for Medicare & Medicaid Services to issue guidance for state Medicaid programs on best practices to support individuals with major depressive disorder or other mental health conditions, including options that include pharmacogenetic testing.

Library of Congress summary, Mar 8, 2023

Summary versions
  • Introduced in SenateMar 8, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.